Amsen D, Blander JM, Lee GR et al (2004) Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell 117:515–526. https://doi.org/10.1016/s0092-8674(04)00451-9
Article CAS PubMed Google Scholar
Ameer MA, Chaudhry H, Mushtaq J et al (2022) An overview of systemic lupus erythematosus (SLE) pathogenesis, classification, and management. Cureus 14:e30330. https://doi.org/10.7759/cureus.30330
Article PubMed PubMed Central Google Scholar
Kwon YC, Chun S, Kim K et al (2019) Update on the genetics of systemic lupus erythematosus: genome-wide association studies and beyond. Cells. https://doi.org/10.3390/cells8101180
Article PubMed PubMed Central Google Scholar
Yaniv G, Twig G, Shor DB et al (2015) A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients. Autoimmun Rev 14:75–79. https://doi.org/10.1016/j.autrev.2014.10.003
Article CAS PubMed Google Scholar
Weeding E, Sawalha AH (2018) Deoxyribonucleic acid methylation in systemic lupus erythematosus: implications for future clinical practice. Front Immunol 9:875. https://doi.org/10.3389/fimmu.2018.00875
Article CAS PubMed PubMed Central Google Scholar
Surace AEA, Hedrich CM (2019) The role of epigenetics in autoimmune/inflammatory disease. Front Immunol 10:1525. https://doi.org/10.3389/fimmu.2019.01525
Article CAS PubMed PubMed Central Google Scholar
Kalled SL, Ambrose C, Hsu YM (2003) BAFF: B cell survival factor and emerging therapeutic target for autoimmune disorders. Expert Opin Ther Targets 7:115–123. https://doi.org/10.1517/14728222.7.1.115
Article CAS PubMed Google Scholar
Mackay F, Woodcock SA, Lawton P et al (1999) Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 190:1697–1710. https://doi.org/10.1084/jem.190.11.1697
Article CAS PubMed PubMed Central Google Scholar
Aringer M (2020) Inflammatory markers in systemic lupus erythematosus. J Autoimmun 110:102374. https://doi.org/10.1016/j.jaut.2019.102374
Article CAS PubMed Google Scholar
Umare VD, Pradhan VD, Rajadhyaksha AG et al (2017) Impact of TNF-α and LTα gene polymorphisms on genetic susceptibility in Indian SLE patients. Hum Immunol 78:201–208. https://doi.org/10.1016/j.humimm.2016.11.002
Article CAS PubMed Google Scholar
Batten M, Groom J, Cachero TG et al (2000) BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med 192:1453–1466. https://doi.org/10.1084/jem.192.10.1453
Article CAS PubMed PubMed Central Google Scholar
Schneider P (2005) The role of APRIL and BAFF in lymphocyte activation. Curr Opin Immunol 17:282–289. https://doi.org/10.1016/j.coi.2005.04.005
Article CAS PubMed Google Scholar
Kirou KA, Lee C, George S et al (2005) Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum 52:1491–1503. https://doi.org/10.1002/art.21031
Article CAS PubMed Google Scholar
González-Serna D, Ortiz-Fernández L, Vargas S et al (2018) Association of a rare variant of the TNFSF13B gene with susceptibility to rheumatoid arthritis and systemic lupus erythematosus. Sci Rep 8:8195. https://doi.org/10.1038/s41598-018-26573-4
Article CAS PubMed PubMed Central Google Scholar
Dhaouadi T, Rojbi I, Ghammouki S et al (2023) Pre- and Post-treatment Serum BAFF Levels and BAFF gene polymorphisms in patients with graves’ disease. Endocr Res 48:16–26. https://doi.org/10.1080/07435800.2023.2167087
Article CAS PubMed Google Scholar
Lane LC, Allinson KR, Campbell K et al (2019) Analysis of BAFF gene polymorphisms in UK Graves’ disease patients. Clin Endocrinol 90:170–174. https://doi.org/10.1111/cen.13872
Fetter T, Niebel D, Braegelmann C et al (2020) Skin-associated B cells in the pathogenesis of cutaneous autoimmune diseases-implications for therapeutic approaches. Cells. https://doi.org/10.3390/cells9122627
Article PubMed PubMed Central Google Scholar
Nobari ST, Nojadeh JN, Talebi M (2022) B-cell maturation antigen targeting strategies in multiple myeloma treatment, advantages and disadvantages. J Transl Med 20:82. https://doi.org/10.1186/s12967-022-03285-y
Article CAS PubMed PubMed Central Google Scholar
Evans LS, Lewis KE, DeMonte D et al (2023) Povetacicept, an enhanced dual APRIL/BAFF antagonist that modulates B lymphocytes and pathogenic autoantibodies for the treatment of lupus and other B cell-related autoimmune diseases. Arthritis Rheumatol Hoboken NJ. https://doi.org/10.1002/art.42462
Flessa CM, Zampeli E, Evangelopoulos ME et al (2022) Genetic variants of the BAFF gene and risk of fatigue among patients with primary sjögren’s syndrome. Front Immunol 13:836824. https://doi.org/10.3389/fimmu.2022.836824
Article CAS PubMed PubMed Central Google Scholar
Santillán-López E, Muñoz-Valle JF, Oregon-Romero E et al (2022) Analysis of TNFSF13B polymorphisms and BAFF expression in rheumatoid arthritis and primary Sjögren’s syndrome patients. Mol Genet Genomic Med 10:e1950. https://doi.org/10.1002/mgg3.1950
Article CAS PubMed PubMed Central Google Scholar
Li S, Zhang Q, Wang P et al (2018) Association between HLA-DQB1 polymorphisms and pemphigus vulgaris: a meta-analysis. Immunol Invest 47:101–112. https://doi.org/10.1080/08820139.2017.1385622
Article CAS PubMed Google Scholar
Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558. https://doi.org/10.1002/sim.1186
Irwig L, Macaskill P, Berry G et al (1998) Bias in meta-analysis detected by a simple, graphical test graphical test is itself biased. BMJ (Clinical research ed) 316:470
CAS PubMed PubMed Central Google Scholar
Kawasaki A, Tsuchiya N, Fukazawa T et al (2002) Analysis on the association of human BLYS (BAFF, TNFSF13B) polymorphisms with systemic lupus erythematosus and rheumatoid arthritis. Genes Immun 3:424–429. https://doi.org/10.1038/sj.gene.6363923
Article CAS PubMed Google Scholar
Marín-Rosales M, Cruz A, Salazar-Camarena DC et al (2019) High BAFF expression associated with active disease in systemic lupus erythematosus and relationship with rs9514828C>T polymorphism in TNFSF13B gene. Clin Exp Med 19:183–190. https://doi.org/10.1007/s10238-019-00549-8
Article CAS PubMed Google Scholar
Zayed RA, Sheba HF, Abo Elazaem MA et al (2013) B-cell activating factor promoter polymorphisms in egyptian patients with systemic lupus erythematosus. Annals Clin Laborat Sci 43:289–294
Hh Y, Hj H, Yp W et al (2022) Correlation between B-cell activation factor gene polymorphisms and patients with hot-toxic blazing systemic lupus erythematosus in Han population in Fujian. Clin J Chin Med 14:23–27
Xw L, Hp G, Xz S et al (2013) Correlation analysis of B cell activating factor promotor polymorphism-871 C/T and systemic lupus erythematosus. Chin J Rheumatol 17:124–126
Fava A, Petri M (2019) Systemic lupus erythematosus: Diagnosis and clinical management. J Autoimmun 96:1–13.
留言 (0)